PATENT CLAIM ANALYSIS

Application Number: 15882475
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "152000"]

Abstract:
The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.

Claim (Index 16):
The compound of  claim 3 , wherein:\n R 1  hydrogen, methyl, or ethyl R 2  is selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, 2,2-dimethylpropyl, t-butyl, isobutyl, n-pentyl, (C 4 -C 6 )cycloalkyl, (C 3 -C 5 )cycloalkylmethyl, methoxyethyl, and 2-fluoroethyl; or R 1  and R 2  taken together with the nitrogen atom to which they are bonded form a ring selected from azetidinyl, pyrrolidinyl, piperidinyl, tetrazolyl, or octahydrocyclopenta[c]pyrrolyl, and wherein the ring formed by R 1  and R 2  taken together with the nitrogen atom to which they are bonded is optionally substituted with fluoro.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 86.0
- Lexical Diversity: 1.44737
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15323081', '13391407', '15296601', '15130358', '14620700']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.801443103456087
- 35 USC 102 Novelty (BERT): 0.5326665998891748
- Combined Prediction Score: 0.7745654530993958
- Mean Citation Score: 353.88025600000014
- Max Citation Score: 361.04553
- Similarity Product: 257.8176645458579

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test